Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma.
Murakami S, Ri M, Ito M, Nakamura N, Kasahara S, Kitagawa J, Inagaki Y, Kuroda J, Yoshimitsu M, Okamoto A, Fukuhara N, Taji H, Iida H, Nagai H, Hanamura I, Tsujimura H, Okura M, Kurata M, Kuwatsuka Y, Atsuta Y, Iida S.
Murakami S, et al. Among authors: taji h.
Int J Hematol. 2022 Oct;116(4):563-569. doi: 10.1007/s12185-022-03379-9. Epub 2022 Jun 14.
Int J Hematol. 2022.
PMID: 35699890